1Bick RL. Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment [ J]. Hematol Oncol Clin North Am. 2003, 17:149 -176. 被引量：1
2Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascalar coagulation: guidelines for rapid and specific laboratory diagnosis[J]. Crit Care Med. 2000, 28:1777-1780. 被引量：1
3Esmon CT. Role of coagulation inhibitors in inflammation[J] . Thromb Haemost. 2001, 86:51-56. 被引量：1
6Mousa SA, Iqbal O, Fareed J. Antithrombotics and thrombolytics in stroke[J]. Curr Opin Investig Drugs. 2002, 3:878～ 885. 被引量：1
7Moake JL, Chow TW. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare[J]. Am J Med Sci. 1998, 316:105 -119. 被引量：1
8Bobbio-Pallavicini E, Gugliotta L, Centurioni R, et al. Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP) . Results of a randomized multicenter trial by the Italian Cooperative Group for TTP[J] .Haematologica. 1997, 82:429 ～ 435. 被引量：1
9Vischer UM, Emcis JJ, Bilo HJ, et al. yon Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf: AgⅡ) [J] .Thromb Haemost. 1998, 80:1002 ～ 1007. 被引量：1
10Vinik A I, Erbas T, Park T S, et al. Platelet Dysfunction in Type 2 Diabetes[J]. Diabetes Care. 2001, 24:1476 ～ 1485. 被引量：1
同被引文献20
1Hosler GA,Cusumano AM,Hutchins GM.Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities:a review of 56 autopsy cases[J].Arch Pathol Lab Med,2003,127(7):834-839. 被引量：1
2Coppo P,Veyradier A,Durey MA,et al.Pathophysiology of thrombotic microangiopathies:current understanding[J].Ann Med Intern(Paris),2002,153(3):153-166. 被引量：1
4Debourdeau PH,Zammit CH,Souleau B,et al.Traitement des microangiopathies thrombotiques[J].Ann Med Intern,1999,150(5):374-387. 被引量：1
5Elliott EJ,Robins-Browne RM,OLonghlin EV.Nationwide study of haemolytic uraemic syndrome:clinical,microbiological,and epidemiological features[J].Arch Dis Child,2001,85:125-131. 被引量：1
6Karmali MA,Petric M,Fleming LC,et al.The association between idiopathic haemolytic uraemic syndrome and infection by verotoxin-producing E coli[J].J Infect Dis,1985,151:775-782. 被引量：1
7Tostivint I,Mougenot B,Flahault A,et al.Adult haemolytic and uraemic syndrome:causes and prognostic factors in the last decade[J].Nephrol Dial Transplant,2002,17:1228-1234. 被引量：1
8Baeyer HV.Plasmapheresis in thrombotic microangiopathy-associated syndrome:review of outcome data derived from clinical trials and open studies[J].Ther Apher,2002,6(4):320-328. 被引量：1
9Martin DJ,Kristine K,MacDonald,et al.The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota[J].N Eng J Med,1990,25:1161-1167. 被引量：1
10Vigneau C,Rondeau E.Hemolytic and uremic syndrome in the adult[J].Nephrologie,2002,23(4):165-171. 被引量：1
